News Home

Should Biotechnology Stock Tarsus Pharmaceuticals Inc (TARS) Be in Your Portfolio Tuesday?

Tuesday, February 20, 2024 03:38 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Tarsus Pharmaceuticals Inc (TARS) Be in Your Portfolio Tuesday?

Tarsus Pharmaceuticals Inc (TARS) is around the top of the Biotechnology industry according to InvestorsObserver. TARS received an overall rating of 78, which means that it scores higher than 78 percent of all stocks. Tarsus Pharmaceuticals Inc also achieved a score of 91 in the Biotechnology industry, putting it above 91 percent of Biotechnology stocks. Biotechnology is ranked 17 out of the 148 industries.

Overall Score - 78
TARS has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on TARS!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Tarsus Pharmaceuticals Inc Stock Today?

Tarsus Pharmaceuticals Inc (TARS) stock is trading at $30.15 as of 3:36 PM on Tuesday, Feb 20, a loss of -$0.55, or -1.79% from the previous closing price of $30.70. The stock has traded between $29.92 and $30.70 so far today. Volume today is below average. So far 250,004 shares have traded compared to average volume of 756,893 shares. Click Here to get the full Stock Report for Tarsus Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App